HLA-DRB1 compatibility in cadaver kidney transplantation

correlation with graft survival and function

F. Poli, L. Mascaretti, M. Pappalettera, M. Scalamogna, L. Bernardi, G. Sirchia

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The introduction of genomic HLA-DR typing has stimulated a re-evaluation of the role of HLA-DR compatibility on cadaver kidney transplantation. We retrospectively studied the influence of HLA-DRB1 matching on the survival of 416 patients using univariate and Cox regression analysis as well as its influence on the occurrence of rejection episodes and on creatinine level at the 3rd month in the 198 recipients for whom these data were available. The following parameters were also considered: HLA-A,B compatibility, donor and recipient age, graft number, pretransplant blood transfusions and panel reactive antibodies (PRA). Twenty-four month graft survival was 100% for transplants with zero mismatches (n=47), 87.9% for those with one mismatch (n-191) and 81.3% for those with two mismatches (n=178). In the Cox model, HLA-DRB1 matching was the most significant variable influencing graft survival (47% of χ2P=0.001), followed by HLA-A,B matching (23%, P=0.02) and donor age (19%, P=0.04). Ninety-two percent of the patients with zero mismatches experienced no rejection episodes in the first 3 posttransplant months compared with 62% and 41% of patients with one and two mismatches, respectively. Mean creatinine level (mg/dl) was 1.2, 1.4, and 1.5 in patients with zero, one, and two mismatches, respectively. Should these results be confirmed by prospective studies, HLA-DRB1 compatibility will have to be considered as an organ allocation criterion.

Original languageEnglish
Pages (from-to)91-95
Number of pages5
JournalTransplant International
Volume8
Issue number2
DOIs
Publication statusPublished - Mar 1995

Fingerprint

HLA-DRB1 Chains
Graft Survival
Cadaver
Kidney Transplantation
HLA-A Antigens
HLA-B Antigens
HLA-DR Antigens
Creatinine
Tissue Donors
Transplants
Histocompatibility Testing
Proportional Hazards Models
Blood Transfusion
Regression Analysis
Prospective Studies
Survival
Antibodies

Keywords

  • Graft survival, HLA-DRB1 kidney
  • HLA-DRB1, kidney transplantation
  • Kidney transplantation, HLA-DRB1

ASJC Scopus subject areas

  • Transplantation

Cite this

Poli, F., Mascaretti, L., Pappalettera, M., Scalamogna, M., Bernardi, L., & Sirchia, G. (1995). HLA-DRB1 compatibility in cadaver kidney transplantation: correlation with graft survival and function. Transplant International, 8(2), 91-95. https://doi.org/10.1007/BF00344417

HLA-DRB1 compatibility in cadaver kidney transplantation : correlation with graft survival and function. / Poli, F.; Mascaretti, L.; Pappalettera, M.; Scalamogna, M.; Bernardi, L.; Sirchia, G.

In: Transplant International, Vol. 8, No. 2, 03.1995, p. 91-95.

Research output: Contribution to journalArticle

Poli, F, Mascaretti, L, Pappalettera, M, Scalamogna, M, Bernardi, L & Sirchia, G 1995, 'HLA-DRB1 compatibility in cadaver kidney transplantation: correlation with graft survival and function', Transplant International, vol. 8, no. 2, pp. 91-95. https://doi.org/10.1007/BF00344417
Poli, F. ; Mascaretti, L. ; Pappalettera, M. ; Scalamogna, M. ; Bernardi, L. ; Sirchia, G. / HLA-DRB1 compatibility in cadaver kidney transplantation : correlation with graft survival and function. In: Transplant International. 1995 ; Vol. 8, No. 2. pp. 91-95.
@article{a8c7c3bd95be4ca4876252dc2e320056,
title = "HLA-DRB1 compatibility in cadaver kidney transplantation: correlation with graft survival and function",
abstract = "The introduction of genomic HLA-DR typing has stimulated a re-evaluation of the role of HLA-DR compatibility on cadaver kidney transplantation. We retrospectively studied the influence of HLA-DRB1 matching on the survival of 416 patients using univariate and Cox regression analysis as well as its influence on the occurrence of rejection episodes and on creatinine level at the 3rd month in the 198 recipients for whom these data were available. The following parameters were also considered: HLA-A,B compatibility, donor and recipient age, graft number, pretransplant blood transfusions and panel reactive antibodies (PRA). Twenty-four month graft survival was 100{\%} for transplants with zero mismatches (n=47), 87.9{\%} for those with one mismatch (n-191) and 81.3{\%} for those with two mismatches (n=178). In the Cox model, HLA-DRB1 matching was the most significant variable influencing graft survival (47{\%} of χ2P=0.001), followed by HLA-A,B matching (23{\%}, P=0.02) and donor age (19{\%}, P=0.04). Ninety-two percent of the patients with zero mismatches experienced no rejection episodes in the first 3 posttransplant months compared with 62{\%} and 41{\%} of patients with one and two mismatches, respectively. Mean creatinine level (mg/dl) was 1.2, 1.4, and 1.5 in patients with zero, one, and two mismatches, respectively. Should these results be confirmed by prospective studies, HLA-DRB1 compatibility will have to be considered as an organ allocation criterion.",
keywords = "Graft survival, HLA-DRB1 kidney, HLA-DRB1, kidney transplantation, Kidney transplantation, HLA-DRB1",
author = "F. Poli and L. Mascaretti and M. Pappalettera and M. Scalamogna and L. Bernardi and G. Sirchia",
year = "1995",
month = "3",
doi = "10.1007/BF00344417",
language = "English",
volume = "8",
pages = "91--95",
journal = "Transplant International",
issn = "0934-0874",
publisher = "Blackwell Publishing Ltd",
number = "2",

}

TY - JOUR

T1 - HLA-DRB1 compatibility in cadaver kidney transplantation

T2 - correlation with graft survival and function

AU - Poli, F.

AU - Mascaretti, L.

AU - Pappalettera, M.

AU - Scalamogna, M.

AU - Bernardi, L.

AU - Sirchia, G.

PY - 1995/3

Y1 - 1995/3

N2 - The introduction of genomic HLA-DR typing has stimulated a re-evaluation of the role of HLA-DR compatibility on cadaver kidney transplantation. We retrospectively studied the influence of HLA-DRB1 matching on the survival of 416 patients using univariate and Cox regression analysis as well as its influence on the occurrence of rejection episodes and on creatinine level at the 3rd month in the 198 recipients for whom these data were available. The following parameters were also considered: HLA-A,B compatibility, donor and recipient age, graft number, pretransplant blood transfusions and panel reactive antibodies (PRA). Twenty-four month graft survival was 100% for transplants with zero mismatches (n=47), 87.9% for those with one mismatch (n-191) and 81.3% for those with two mismatches (n=178). In the Cox model, HLA-DRB1 matching was the most significant variable influencing graft survival (47% of χ2P=0.001), followed by HLA-A,B matching (23%, P=0.02) and donor age (19%, P=0.04). Ninety-two percent of the patients with zero mismatches experienced no rejection episodes in the first 3 posttransplant months compared with 62% and 41% of patients with one and two mismatches, respectively. Mean creatinine level (mg/dl) was 1.2, 1.4, and 1.5 in patients with zero, one, and two mismatches, respectively. Should these results be confirmed by prospective studies, HLA-DRB1 compatibility will have to be considered as an organ allocation criterion.

AB - The introduction of genomic HLA-DR typing has stimulated a re-evaluation of the role of HLA-DR compatibility on cadaver kidney transplantation. We retrospectively studied the influence of HLA-DRB1 matching on the survival of 416 patients using univariate and Cox regression analysis as well as its influence on the occurrence of rejection episodes and on creatinine level at the 3rd month in the 198 recipients for whom these data were available. The following parameters were also considered: HLA-A,B compatibility, donor and recipient age, graft number, pretransplant blood transfusions and panel reactive antibodies (PRA). Twenty-four month graft survival was 100% for transplants with zero mismatches (n=47), 87.9% for those with one mismatch (n-191) and 81.3% for those with two mismatches (n=178). In the Cox model, HLA-DRB1 matching was the most significant variable influencing graft survival (47% of χ2P=0.001), followed by HLA-A,B matching (23%, P=0.02) and donor age (19%, P=0.04). Ninety-two percent of the patients with zero mismatches experienced no rejection episodes in the first 3 posttransplant months compared with 62% and 41% of patients with one and two mismatches, respectively. Mean creatinine level (mg/dl) was 1.2, 1.4, and 1.5 in patients with zero, one, and two mismatches, respectively. Should these results be confirmed by prospective studies, HLA-DRB1 compatibility will have to be considered as an organ allocation criterion.

KW - Graft survival, HLA-DRB1 kidney

KW - HLA-DRB1, kidney transplantation

KW - Kidney transplantation, HLA-DRB1

UR - http://www.scopus.com/inward/record.url?scp=0028910657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028910657&partnerID=8YFLogxK

U2 - 10.1007/BF00344417

DO - 10.1007/BF00344417

M3 - Article

VL - 8

SP - 91

EP - 95

JO - Transplant International

JF - Transplant International

SN - 0934-0874

IS - 2

ER -